Skip to content
← Back to this collection

PUBLICATIONS · 10561337

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1999 Sep
First author
Cobleigh MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Mar 10;41(8):1501-1510. doi: 10.1200/JCO.22.02510.
    note
    Source null
    related pmid
    36881998
    relationship
    Republished in

Authors and identifiers

  1. name
    Cobleigh MA
    type
    Author
  2. name
    Vogel CL
    type
    Author
  3. name
    Tripathy D
    type
    Author
  4. name
    Robert NJ
    type
    Author
  5. name
    Scholl S
    type
    Author
  6. name
    Fehrenbacher L
    type
    Author
  7. name
    Wolter JM
    type
    Author
  8. name
    Paton V
    type
    Author
  9. name
    Shak S
    type
    Author
  10. name
    Lieberman G
    type
    Author
  11. name
    Slamon DJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cobleigh MA
    type
    Author
  2. name
    Vogel CL
    type
    Author
  3. name
    Tripathy D
    type
    Author
  4. name
    Robert NJ
    type
    Author
  5. name
    Scholl S
    type
    Author
  6. name
    Fehrenbacher L
    type
    Author
  7. name
    Wolter JM
    type
    Author
  8. name
    Paton V
    type
    Author
  9. name
    Shak S
    type
    Author
  10. name
    Lieberman G
    type
    Author
  11. name
    Slamon DJ
    type
    Author
bibliography ids
  1. nci-bib-71618daa64b26b2c902941d8
book metadata
content sha256
35a29ed2bf64c7199baf461aa60acd19372372fc99b9f8bfb608b4bc19e82a68
document type
citation
dois
  1. 10.1200/JCO.1999.17.9.2639
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:10561337
immutable id
pubmed:10561337@35a29ed2bf64c7199baf461aa60acd19372372fc99b9f8bfb608b4bc19e82a68
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
9
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2639-48
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Mar 10;41(8):1501-1510. doi: 10.1200/JCO.22.02510.
    note
    Source null
    related pmid
    36881998
    relationship
    Republished in
outcomes validated
false
pmid
10561337
provenance
batch id
40703d4bdd5a70d2c67a
provider
NCBI PubMed ESummary
record sha256
da1fe0c8f486a22b5fa279d29c4bbe4be7c89634db67043c686daaefebfd73f1
response sha256
a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
retrieved at
2026-09-09T23:45:35.800055+00:00
publication date
display
1999 Sep
precision
month
year
1999
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/10561337/
title
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.

Preserved source evidence · Not medical advice